Michael Higgins

Mr. Michael J.
Higgins is an Independent Director at Nocion Therapeutics, Inc., a Chairman at Voyager Therapeutics, Inc., a Chairman at Pulmatrix, Inc. and a Chief Executive Officer & Director at KinDex Pharmaceuticals, Inc. He is on the Board of Directors at Nocion Therapeutics, Inc., Madauder Therapeutics, Inc., Sea Pharmaceuticals LLC, KinDex Pharmaceuticals, Inc., Morgan Stanley Private Equity Access Fund II LP and Private Equity Access Fund II.
Mr. Higgins was previously employed as an Independent Director by Cyclerion Therapeutics, Inc., an Independent Director by CAMP4 Therapeutics Corp., an Independent Director by Genocea Biosciences, Inc., a Chief Financial Officer by Boston Business Journal, a Chief Operating Officer by Ironwood Pharmaceuticals, Inc., a VP-Corporate Finance & Business Development by Genzyme Corp., and a Chief Financial Officer by Procept, Inc. He also served on the board at Ruthigen, Inc., Pulmatrix, Inc /Old/ and Microbia, Inc. He received his undergraduate degree from Cornell University and an MBA from Tuck School of Business at Dartmouth.